Elite Pharmaceuticals Files 8-K
Ticker: ELTP · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1053369
| Field | Detail |
|---|---|
| Company | Elite Pharmaceuticals INC /NV/ (ELTP) |
| Form Type | 8-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-statements
TL;DR
Elite Pharma filed a routine 8-K on 4/30/25. Check exhibits for news.
AI Summary
Elite Pharmaceuticals, Inc. filed an 8-K on April 30, 2025, reporting on financial statements and exhibits. The company, incorporated in Nevada with its principal executive offices in Northvale, New Jersey, previously operated under the name Elite Pharmaceuticals Inc /DE/ before a name change on January 21, 1998. The filing does not disclose specific financial figures or events beyond its routine reporting nature.
Why It Matters
This filing indicates Elite Pharmaceuticals is meeting its regulatory reporting obligations. Investors can review the disclosed exhibits for any material updates.
Risk Assessment
Risk Level: low — This is a routine SEC filing that does not appear to contain new material information or significant financial events.
Key Players & Entities
- ELITE PHARMACEUTICALS, INC. (company) — Registrant
- ELITE PHARMACEUTICALS INC /NV/ (company) — Exact name of registrant
- Nevada (jurisdiction) — State of incorporation
- 001-15697 (identifier) — Commission File Number
- 22-3542636 (identifier) — IRS Employer Identification No.
- 165 Ludlow Avenue (address) — Principal executive offices street
- Northvale (location) — Principal executive offices city
- New Jersey (location) — Principal executive offices state
- 07647 (zip_code) — Principal executive offices zip
- (201) 750-2646 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits as of April 30, 2025.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is ELITE PHARMACEUTICALS, INC.
In which state is Elite Pharmaceuticals, Inc. incorporated?
Elite Pharmaceuticals, Inc. is incorporated in Nevada.
What is the company's former name and when did the name change occur?
The company's former name was ELITE PHARMACEUTICALS INC /DE/, and the date of the name change was January 21, 1998.
What is the address of the principal executive offices?
The address of the principal executive offices is 165 Ludlow Avenue, Northvale, New Jersey 07647.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding ELITE PHARMACEUTICALS INC /NV/ (ELTP).